In pooled STEP 1-3 data on the 2.4 mg dose, nausea occurred in 43.9% (vs 16.1% placebo), diarrhea in 29.7% (vs 15.9%), vomiting in 24.5% (vs 6.3%), and constipation in 24.2% (vs 11.1%)
If appetite suppression leads to low energy intake over time, the body may reduce reproductive hormone signaling as a protective responsesometimes resulting in lighter, delayed, or missing periods
Capehorn MS, Catarig AM, Furberg JK, et al
Candidates for Semaglutide have a BMI over 30, or over 27 with at least one related condition such as high blood pressure, high cholesterol or diabetes (Type 2)
The semaglutide with B12 combination is designed to prevent deficiency, not to cause additional problems
Switching to a concentration that produces whole-number unit measurements for your most common doses simplifies the math and improves consistency